<p>隨着全球市場因貿易談判和經濟指標而發生變化，亞洲市場因其獨特的動態和機會而備受關注。在這種環境下，識別具有強大基本面和增長潛力的股票尤其具有回報，特別是在投資者尋求應對不斷變化的市場格局時。</p>
<h3>亞洲十大未被發現的基本面強勁的寶藏股</h3>
<table>
<thead>
<tr>
<th>名稱</th>
<th>負債權益比</th>
<th>收入增長</th>
<th>盈利增長</th>
<th>健康評級</th>
</tr>
</thead>
<tbody>
<tr>
<td>湖北三峽旅遊集團</td>
<td>11.24%</td>
<td>-15.32%</td>
<td>17.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>韓國評級</td>
<td>NA</td>
<td>0.74%</td>
<td>1.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>小西</td>
<td>0.15%</td>
<td>0.46%</td>
<td>12.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>紅綿智慧科技創新有限公司（廣州）</td>
<td>11.90%</td>
<td>-28.99%</td>
<td>46.16%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>安吉食品</td>
<td>NA</td>
<td>9.94%</td>
<td>-16.40%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>JHT 設計有限公司</td>
<td>2.19%</td>
<td>33.65%</td>
<td>-8.51%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>上海海鑫集團</td>
<td>0.78%</td>
<td>-0.42%</td>
<td>8.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>廣東天德醫療電子</td>
<td>18.69%</td>
<td>-7.58%</td>
<td>-3.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳龍科技智能控制</td>
<td>8.06%</td>
<td>18.09%</td>
<td>13.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳東拓供應鏈管理</td>
<td>73.12%</td>
<td>-30.87%</td>
<td>-1.20%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們亞洲未被發現的基本面強勁的寶藏股篩選器中的 2704 只股票的完整列表。</p>
<p>在這裏，我們突出了一部分我們篩選器中首選的股票。</p>
<h2>上海康耐視光學（SEHK:2276）</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 上海康耐視光學有限公司是一家在多個地區（包括中國大陸、美洲、亞洲、歐洲、大洋洲和非洲）製造和銷售樹脂眼鏡鏡片的公司，市值為 124.1 億港元。</p>
<p><strong>運營：</strong> 上海康耐視光學的主要收入來源於樹脂眼鏡鏡片的製造和銷售，收入為 20.6 億人民幣。</p>
<p>上海康耐視光學最近的表現描繪了一幅樂觀的圖景，盈利增長 31%，超過醫療設備行業的 9.6%。該公司 2024 年的淨收入達到 4.2828 億人民幣，較去年 3.2702 億人民幣顯著增長，而基本每股收益從 0.77 元上升至 1.03 元。其債務的利息支付由 EBIT 以超過 104 倍的比率良好覆蓋，突顯了該小型企業在亞洲繁忙市場環境中的強大財務健康和穩定性。</p>
<ul>
<li>點擊這裏瞭解上海康耐視光學的細微差別，查看我們的詳細分析健康報告。</li>
<li>通過訪問我們的歷史表現報告，評估上海康耐視光學的歷史表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth"/></p>
<p>SEHK:2276 截至 2025 年 5 月的盈利和收入增長</p>
<h2>博創科技（SZSE:300548）</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 博創科技有限公司專注於光通信集成光電設備的研究、開發、生產和銷售，市值約為 131.6 億人民幣。</p>
<p><strong>運營：</strong> 博創科技的收入主要來自光通信集成光電設備的銷售。公司的淨利潤率顯示出顯著的趨勢，反映其財務表現的動態。</p>
<p>博創科技作為科技行業的一個重要參與者，最近展示了令人印象深刻的增長，過去一年盈利增長 309.9%，遠超行業平均的-2.1%。目前交易價格比其估計的公允價值低 47%，為尋求被低估資產的投資者提供了一個引人注目的機會。該公司報告第一季度銷售額為 5.3851 億人民幣，淨收入為 8970 萬人民幣，較去年數據顯著躍升。儘管最近股價波動，博創的財務健康得益於現金超過總債務和正的自由現金流狀態。</p>
<ul>
<li>在我們的健康報告中更深入地瞭解博創科技的潛力。</li>
<li>通過查看我們的歷史表現報告，獲取博創科技的歷史表現見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300548 截至 2025 年 5 月的盈利和收入增長</p>
<h2>DTS（TSE:9682）</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> DTS Corporation 是一家日本公司，專注於系統集成服務，市值為 1839.6 億日元。</p>
<p><strong>運營：</strong> 該公司主要通過其系統集成服務產生收入。市值為 1839.6 億日元。</p>
<p>DTS 作為 IT 行業的小型但有前景的參與者，正在進行戰略性舉措，專注於創新和股東價值。該公司報告過去一年盈利增長 45.8%，超過行業平均的 10.8%。目前交易價格比其公允價值估計低 10.2%，相較於同行提供了良好的相對價值。最近的股票回購計劃旨在在 2025 年 7 月之前回購 75 萬股，金額為 25 億日元，提高資本效率和股東回報。組織變革強調生成式 AI 倡議和全球業務擴展，以推動未來的增長機會。</p>
<ul>
<li>在這份健康報告中解鎖我們對 DTS 股票分析的全面見解。</li>
<li>瞭解 DTS 的歷史表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth"/></p>
<p>TSE:9682 截至 2025 年 5 月的盈利和收入增長</p>
<h2>利用機會</h2>
<ul>
<li>點擊這裏解鎖我們全面的 2704 個亞洲未被發現的優質股票名單，具有強大的基本面。</li>
<li>持有這些公司的股票？在 Simply Wall St 上設置您的投資組合，以無縫跟蹤您的投資並接收個性化的投資組合表現更新。</li>
<li>使用 Simply Wall St 提升您的投資組合，這是尋求全球市場覆蓋的投資者的終極應用程序。</li>
</ul>
<h2>尋找新的視角？</h2>
<ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>用顯示強勁增長潛力的公司來充實您的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
<li>尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成購買或出售任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<p>如果您想交易 DTS，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
<p>IBKR 在超過 200 個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
<p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的費用。</p>
<p>贊助內容</p>

長芯博創

9682

<p>這篇文章強調了三隻具有強勁增長潛力的亞洲股票：上海康耐視光學、博創科技和 DTS 公司。上海康耐視光學市值為 124.1 億港元，報告了 31% 的盈利增長，而博創科技的盈利增長則達到了驚人的 309.9%。DTS 公司的市值為 1839.6 億日元，實現了 45.8% 的盈利增長。每家公司都展現出強大的基本面，並在各自的市場中處於良好位置，使它們成為尋求被低估資產的投資者在亞洲市場中的有吸引力的選擇</p>

<p>As global markets experience shifts driven by trade negotiations and economic indicators, Asian markets are drawing attention with their unique dynamics and opportunities. In this environment, identifying stocks with strong fundamentals and growth potential can be particularly rewarding, especially as investors seek to navigate the evolving landscape.</p>
<div class="lb-trans"><p>隨着全球市場因貿易談判和經濟指標而發生變化，亞洲市場因其獨特的動態和機會而備受關注。在這種環境下，識別具有強大基本面和增長潛力的股票尤其具有回報，特別是在投資者尋求應對不斷變化的市場格局時。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals In Asia</h3>
<div class="lb-trans"><h3>亞洲十大未被發現的基本面強勁的寶藏股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hubei Three Gorges Tourism Group</td>
<td>11.24%</td>
<td>-15.32%</td>
<td>17.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Korea Ratings</td>
<td>NA</td>
<td>0.74%</td>
<td>1.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Konishi</td>
<td>0.15%</td>
<td>0.46%</td>
<td>12.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Hongmian Zhihui Science and Technology InnovationLtd.Guangzhou</td>
<td>11.90%</td>
<td>-28.99%</td>
<td>46.16%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Anji Foodstuff</td>
<td>NA</td>
<td>9.94%</td>
<td>-16.40%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>JHT DesignLtd</td>
<td>2.19%</td>
<td>33.65%</td>
<td>-8.51%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Shanghai Haixin Group</td>
<td>0.78%</td>
<td>-0.42%</td>
<td>8.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Guangdong Transtek Medical Electronics</td>
<td>18.69%</td>
<td>-7.58%</td>
<td>-3.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Shenzhen Longtech Smart Control</td>
<td>8.06%</td>
<td>18.09%</td>
<td>13.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Shenzhen Easttop Supply Chain Management</td>
<td>73.12%</td>
<td>-30.87%</td>
<td>-1.20%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名稱</th>
<th>負債權益比</th>
<th>收入增長</th>
<th>盈利增長</th>
<th>健康評級</th>
</tr>
</thead>
<tbody>
<tr>
<td>湖北三峽旅遊集團</td>
<td>11.24%</td>
<td>-15.32%</td>
<td>17.90%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>韓國評級</td>
<td>NA</td>
<td>0.74%</td>
<td>1.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>小西</td>
<td>0.15%</td>
<td>0.46%</td>
<td>12.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>紅綿智慧科技創新有限公司（廣州）</td>
<td>11.90%</td>
<td>-28.99%</td>
<td>46.16%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>安吉食品</td>
<td>NA</td>
<td>9.94%</td>
<td>-16.40%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>JHT 設計有限公司</td>
<td>2.19%</td>
<td>33.65%</td>
<td>-8.51%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>上海海鑫集團</td>
<td>0.78%</td>
<td>-0.42%</td>
<td>8.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>廣東天德醫療電子</td>
<td>18.69%</td>
<td>-7.58%</td>
<td>-3.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳龍科技智能控制</td>
<td>8.06%</td>
<td>18.09%</td>
<td>13.26%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>深圳東拓供應鏈管理</td>
<td>73.12%</td>
<td>-30.87%</td>
<td>-1.20%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 2704 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們亞洲未被發現的基本面強勁的寶藏股篩選器中的 2704 只股票的完整列表。</p>
</div><p>Here we highlight a subset of our preferred stocks from the screener.</p>
<div class="lb-trans"><p>在這裏，我們突出了一部分我們篩選器中首選的股票。</p>
</div><h2>Shanghai Conant Optical (SEHK:2276)</h2>
<div class="lb-trans"><h2>上海康耐視光學（SEHK:2276）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Shanghai Conant Optical Co., Ltd. is a company that manufactures and sells resin spectacle lenses across multiple regions including Mainland China, the Americas, Asia, Europe, Oceania, and Africa with a market capitalization of HK$12.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 上海康耐視光學有限公司是一家在多個地區（包括中國大陸、美洲、亞洲、歐洲、大洋洲和非洲）製造和銷售樹脂眼鏡鏡片的公司，市值為 124.1 億港元。</p>
</div><p><strong>Operations:</strong> The primary revenue stream for Shanghai Conant Optical comes from the manufacturing and sales of resin spectacle lenses, generating CN¥2.06 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 上海康耐視光學的主要收入來源於樹脂眼鏡鏡片的製造和銷售，收入為 20.6 億人民幣。</p>
</div><p>Shanghai Conant Optical's recent performance paints a promising picture, with earnings growth of 31% outpacing the Medical Equipment industry's 9.6%. The company's net income for 2024 reached CNY 428.28 million, a notable increase from CNY 327.02 million in the previous year, while basic earnings per share rose to CNY 1.03 from CNY 0.77. Interest payments on its debt are well-covered by EBIT at an impressive ratio of over 104 times, highlighting strong financial health and stability within this small cap entity in Asia's bustling market landscape.</p>
<div class="lb-trans"><p>上海康耐視光學最近的表現描繪了一幅樂觀的圖景，盈利增長 31%，超過醫療設備行業的 9.6%。該公司 2024 年的淨收入達到 4.2828 億人民幣，較去年 3.2702 億人民幣顯著增長，而基本每股收益從 0.77 元上升至 1.03 元。其債務的利息支付由 EBIT 以超過 104 倍的比率良好覆蓋，突顯了該小型企業在亞洲繁忙市場環境中的強大財務健康和穩定性。</p>
</div><ul>
<li>Click here to discover the nuances of Shanghai Conant Optical with our detailed analytical health report.</li>
<li>Evaluate Shanghai Conant Optical's historical performance by accessing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏瞭解上海康耐視光學的細微差別，查看我們的詳細分析健康報告。</li>
<li>通過訪問我們的歷史表現報告，評估上海康耐視光學的歷史表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/aa2aed6f-3c06-436e-b008-7096614d2df1/chart/earnings-and-revenue-growth"/></p>
<p>SEHK:2276 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>SEHK:2276 截至 2025 年 5 月的盈利和收入增長</p>
</div><h2>Broadex Technologies (SZSE:300548)</h2>
<div class="lb-trans"><h2>博創科技（SZSE:300548）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Broadex Technologies Co., Ltd. focuses on the research, development, production, and sale of integrated optoelectronic devices for optical communications both in China and globally, with a market cap of approximately CN¥13.16 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 博創科技有限公司專注於光通信集成光電設備的研究、開發、生產和銷售，市值約為 131.6 億人民幣。</p>
</div><p><strong>Operations:</strong> Broadex Technologies generates revenue primarily from the sale of integrated optoelectronic devices for optical communications. The company's net profit margin has shown notable trends, reflecting its financial performance dynamics.</p>
<div class="lb-trans"><p><strong>運營：</strong> 博創科技的收入主要來自光通信集成光電設備的銷售。公司的淨利潤率顯示出顯著的趨勢，反映其財務表現的動態。</p>
</div><p>Broadex Technologies, a notable player in the tech sector, recently showcased impressive growth with earnings rising 309.9% over the past year, far outpacing the industry average of -2.1%. Trading at 47% below its estimated fair value, it presents an intriguing opportunity for investors seeking undervalued assets. The company reported first-quarter sales of CNY 538.51 million and net income of CNY 89.7 million, a significant leap from last year's figures. Despite a volatile share price recently, Broadex's financial health is bolstered by having more cash than total debt and positive free cash flow status.</p>
<div class="lb-trans"><p>博創科技作為科技行業的一個重要參與者，最近展示了令人印象深刻的增長，過去一年盈利增長 309.9%，遠超行業平均的-2.1%。目前交易價格比其估計的公允價值低 47%，為尋求被低估資產的投資者提供了一個引人注目的機會。該公司報告第一季度銷售額為 5.3851 億人民幣，淨收入為 8970 萬人民幣，較去年數據顯著躍升。儘管最近股價波動，博創的財務健康得益於現金超過總債務和正的自由現金流狀態。</p>
</div><ul>
<li>Take a closer look at Broadex Technologies' potential here in our health report.</li>
<li>Gain insights into Broadex Technologies' historical performance by reviewing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的健康報告中更深入地瞭解博創科技的潛力。</li>
<li>通過查看我們的歷史表現報告，獲取博創科技的歷史表現見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300548 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>SZSE:300548 截至 2025 年 5 月的盈利和收入增長</p>
</div><h2>DTS (TSE:9682)</h2>
<div class="lb-trans"><h2>DTS（TSE:9682）</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> DTS Corporation is a Japanese company specializing in systems integration services with a market capitalization of ¥183.96 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> DTS Corporation 是一家日本公司，專注於系統集成服務，市值為 1839.6 億日元。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily through its systems integration services. It has a market capitalization of ¥183.96 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司主要通過其系統集成服務產生收入。市值為 1839.6 億日元。</p>
</div><p>DTS, a small but promising player in the IT sector, has been making strategic moves with a focus on innovation and shareholder value. The company reported impressive earnings growth of 45.8% over the past year, outpacing the industry average of 10.8%. Trading at 10.2% below its fair value estimate, DTS offers good relative value compared to peers. A recent share repurchase plan aims to buy back 750,000 shares for ¥2.5 billion by July 2025, enhancing capital efficiency and shareholder returns. Organizational changes emphasize generative AI initiatives and global business expansion to drive future growth opportunities.</p>
<div class="lb-trans"><p>DTS 作為 IT 行業的小型但有前景的參與者，正在進行戰略性舉措，專注於創新和股東價值。該公司報告過去一年盈利增長 45.8%，超過行業平均的 10.8%。目前交易價格比其公允價值估計低 10.2%，相較於同行提供了良好的相對價值。最近的股票回購計劃旨在在 2025 年 7 月之前回購 75 萬股，金額為 25 億日元，提高資本效率和股東回報。組織變革強調生成式 AI 倡議和全球業務擴展，以推動未來的增長機會。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of DTS stock in this health report.</li>
<li>Learn about DTS' historical performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這份健康報告中解鎖我們對 DTS 股票分析的全面見解。</li>
<li>瞭解 DTS 的歷史表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/fdd1bfd1-c0c8-49ab-b832-d604e05dd040/chart/earnings-and-revenue-growth"/></p>
<p>TSE:9682 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>TSE:9682 截至 2025 年 5 月的盈利和收入增長</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用機會</h2>
</div><ul>
<li>Unlock our comprehensive list of 2704 Asian Undiscovered Gems With Strong Fundamentals by clicking here.</li>
<li>Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.</li>
<li>Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏解鎖我們全面的 2704 個亞洲未被發現的優質股票名單，具有強大的基本面。</li>
<li>持有這些公司的股票？在 Simply Wall St 上設置您的投資組合，以無縫跟蹤您的投資並接收個性化的投資組合表現更新。</li>
<li>使用 Simply Wall St 提升您的投資組合，這是尋求全球市場覆蓋的投資者的終極應用程序。</li>
</ul>
</div><h2>Searching for a Fresh Perspective?</h2>
<div class="lb-trans"><h2>尋找新的視角？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>用顯示強勁增長潛力的公司來充實您的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
<li>尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成購買或出售任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><p>If you're looking to trade DTS, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 DTS，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在超過 200 個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的費用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>贊助內容</p>
</div>

探索三隻具有強勁潛力的亞洲股票